Trial Profile
An expanded access program for Traumakine
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 05 Sep 2017
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Adult respiratory distress syndrome
- Focus Expanded access; Therapeutic Use
- 05 Sep 2017 New trial record